Overview:
The United States is currently experiencing an opioid epidemic. There are 2 million Americans meeting the criteria for opioid use disorders due to prescription opioid use and an additional 0.5 million meeting criteria due to their heroin use. Deaths from opioid overdoses are now comparable to vehicle crash deaths and opioid misuse is estimated to cost society more than $55 billion per year. While medications have been researched and documented as effective clinical interventions to address the significant medical, emotional, criminal justice, and societal costs, less than 30% of treatment programs offer medications and less than half of eligible patients in those programs receive medications.
Opioid use disorder (OUD) is increasingly encountered in clinical settings, and highly effective FDA-approved medications are available for its treatment. This course will introduce recommendations for evidence-based treatment for opioid use disorders that support the use of medication to assist clinicians in clinical decision-making and patient management.
Objectives:
- Identify the rationale for using medications to treat opioid use disorder.
- Identify the FDA-approved pharmacological treatments for OUD.
- Describe the properties of the three common medications used in pharmacotherapy.
- Explain the unique properties of methadone, buprenorphine, and naltrexone.
- Describe the safety and efficacy and the benefits and limitations of available medications.
Course materials are only available to enrolled students.
-
Sharon Halliday, MD
Dr. Sharon Halliday is a respected psychiatrist with a deep commitment to improving the lives of individuals with substance use, abuse, dependence, and mental health disorders. As the Program Director and Clinical Supervisor at RAPHA Healthcare Services, and a practicing psychiatrist at Medical Associates in St. Kitts and Nevis, Dr. Halliday is at the forefront of efforts to understand and address the complex challenges facing individuals with these conditions. Dr. Halliday's primary focus is on the dual diagnosed and revolving door patients, recidivists, and the ways in which substance use, abuse, and dependence worsen the overall prognosis in these patients. She is also deeply interested in how mental health and substance abuse contribute to the overall global burden of disease and in the development of policies that can help reduce this burden. Dr. Halliday has extensive experience working with clients in medication-assisted treatment programs and has been licensed as a psychiatrist and prescriber of suboxone in North Carolina. She holds current active medical licenses in St. Kitts and Nevis and in Anguilla, where she continues to provide critical care and support to those in need. Throughout her career, Dr. Halliday has demonstrated a commitment to advancing her clinical and administrative/managerial skills and to working collaboratively with teams to provide the best possible care for her clients. Her expertise in dealing with dual-diagnosed clients and those diagnosed with substance use and/or mental health disorders is highly valued in today's society, where these conditions continue to represent significant challenges for individuals, families, and communities.
Board Approvals




Additional Board Information:
States that Accept ASWB-ACE Approved Courses |
||||||
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut |
Delaware | District Of Columbia | Florida | Georgia | Hawaii | Idaho | Illinois |
Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland |
Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska |
Nevada | New Hampshire | New Jersey | New Mexico | North Carolina | North Dakota | Ohio |
Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee |
Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin |
Wyoming |
States that Accept NBCC Approved Courses: |
||||||
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut |
Delaware | District Of Columbia | Florida | Georgia | Hawaii | Idaho | Indiana |
Iowa | Maine | Maryland | Missouri | New Hampshire | New Jersey | New Mexico |
Ohio | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee |
Texas | Vermont | Virginia | Washington | Wisconsin |
- Nevada CPC’s and MFT’s accept ASWB-approved training
- North Dakota Board Of Counselor Examiners LAPC and LAPCS accept ASWB approved training
- Rhode Island Board of Mental Health Counselors and Marriage & Family Therapists MHC’s accept ASWB approved training
- Texas Behavioral Health Executive Council LPC and LPCS accept ASWB approved training
- Utah Division of Professional Licensing - CMHC’s accept ASWB approved training
- Washington State Department of Mental Health MHC’s accept ASWB approved training
- Wisconsin Council on Mental Health LPCS accepts ASWB-approved training
States that Accept NAADAC-Approved Courses: |
||||||
Alabama | Alaska | Arizona | Arkansas | Delaware | Hawaii | Indiana |
Kentucky | Maine | Massachusetts | Minnesota | Montana | Nevada | New Jersey |
New Jersey | New Mexico | North Carolina | North Dakota | Oregon | Rhode Island | Tennessee |
Vermont | Virginia | Washington | West Virginia | Wisconsin | Wisconsin | Wyoming |
Other Board Approvals:
- California Consortium of Addiction Programs and Professionals (CCAPP): E Care BHI is recognized by the California Consortium of Addiction Programs and Professionals (CCAPP) Provider Number OS-22-344-0424
- Connecticut Certification Board (CCB Approved): E Care BHI is recognized & approved by the Connecticut Certification Board.
- Georgia Addiction Counselor: E Care BHI is recognized by the Alcohol and Drug Abuse Certification Board of Georgia as an approved education provider for Addiction Counselors (ADACBGA) #19-12-17-1212.
- Florida Addiction Counselor: E Care BHI is recognized by the Florida Certification Board as an approved education provider for Addiction Counselor (FCB) #5387-A.
- Florida Board of Clinical Social Work, Marriage & Family Therapy & Mental Health Counseling: The Florida Board of Clinical Social Work, Marriage & Family Therapy & Mental Health Counseling accepts courses from ASWB & NBCC-approved providers. E Care Behavioral Health Institute is an ASWB and NBCC-approved provider.
- Minnesota Certification Board accepts CCAPP. E Care is an approved training provider by California Consortium of Addiction Programs and Professionals (CCAPP): E Care BHI is recognized by the California Consortium of Addiction Programs and Professionals (CCAPP) Provider Number OS-22-344-0424
- Oklahoma Addiction Counselor: E Care BHI is recognized by the Oklahoma State Board of Licensed Alcohol and Drug Counselors as an approved education provider for Addiction Counselors (OBLADC) #20220136.
- Ohio Addiction Counselor: E Care BHI is recognized by the Ohio Chemical Dependency Professionals Board as an approved education provider for Addiction Counselor (OCDP)#50-29024
- South Carolina Professional Counselors, Marriage & Family Therapists and Psycho-Educational Specialists licensing board, Provider #462
- The Ohio Counselor, Social Worker, and Marriage and Family Therapist Board accepts courses from ASWB & NBCC approved providers. E Care Behavioral Health Institute is an ASWB and NBCC approved provider.
- Texas Certification Board (TCB): E Care Behavioral BHI is recognized by the Texas Certification Board. Provider Number 2041-19
- VA Mental Health Employee: E Care BHI VA COMMERCIAL VENDOR # 81-3353387-01